BUMC Thrombotic Microangiopathy Collaborative (BUTMAC)

Our Mission

The Boston University Thrombotic Microangiopathy Collaborative (BUTMAC) provides a multidisciplinary approach to the care of patients with TMA. The multidisciplinary team is very unique in its structure and function, involving physicians from different subspecialties with great interest and expertise in managing patients with TMA.

The Collaborative combines basic and clinical research to advance the understanding of the TMA syndromes. We are integral part of the Affinity Research Collaborative (ARC) on Thrombosis and Homeostasis that consists of investigators from several academic departments with a common goal to investigate thrombosis in humans (http://www.bumc.bu.edu/evanscenteribr/the-arcs/the-arcs/).

  • Evaluation, management and treatment of patients with TMA.
  • To educate other health providers and increase awareness of the TMA syndromes
  • Center for clinical trials and basic research on TMA syndromes.
  • Role model for the management of patients with TMA through a multidisciplinary team approach.

Patients Frequently Asked Questions

For referring physicians

The BUTMAC is committed to provide a high quality of care without exception to all patients with TMA. Our TMA team has a great experience in managing patients with TMA. Our goal is to maintain the highest standards of patient care based on collegiality and continuous communication with referring physicians. Our team members are readily available to respond to referring physician requests and questions at any time via phone, or electronic mail regardless of having seen the patient or not. Our TMA center is involved in TMA clinical trials to keep advancing the understanding, management and treatment of this complex disease. Please contact Dr. Jean Francis at Jean.Francis@bmc.org and Dr. Vipul Chitalia at Vipul.Chitalia@bmc.org.